

Samuel Asculai, Enhance Skin Products Inc: Profile & Biography - Bloomberg


































































  



























Feedback





Samuel Asculai

Chairman/Chief Scientific Ofcr,
Enhance Skin Products Inc






Career History




Owner
 Biostrategies Consulting, PRESENT


Chairman/Chief Scientific Ofcr
Enhance Skin Products Inc, PRESENT


President/CEO/Owner
Enhance Skin Products Inc, 8/2008-2/2013


Chief Scientific Ofcr
Enhance Skin Products Inc, 2/2013-UNKNOWN


President/CEO
Hyal Pharmaceutical Corp, FORMER



Verigen AG, FORMER



Monsanto Corporation, FORMER



Ortho Pharmaceutical Corp, FORMER


Show More









Website:
www.enhanceskinproducts.com






Corporate Information
Address:

695 South Colorado Boulevard
Suite 480
Denver, CO 80246
United States


Phone:
1-800-817-7161


Fax:
-


Web url:
www.enhanceskinproducts.com











From The Web












Personal Information



Education



Rutgers The State University of New Jersey
PhD, Microbiology


Rutgers The State University of New Jersey
Master's Degree








Memberships



Board Memberships




 Biostrategies Consulting


Board Member, PRESENT




Enhance Skin Products Inc


Chairman, PRESENT




Enhance Skin Products Inc


Board Member, 8/2008-2/2013




Hyal Pharmaceutical Corp


Board Member, 1990-8/1999




Hyal Pharmaceutical Australia


Board Member, FORMER




Enhance Skin Products Inc


Board Member, 2/2013-UNKNOWN



Show More








Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data
































    Samuel Asculai | Verigen AG | ZoomInfo.com


Samuel Asculai | Facebook





Facebook邮箱或手机号密码忘记帐户？Samuel AsculaiSamuel Asculai 正在使用 Facebook。注册 Facebook，与 Samuel Asculai 建立联系。登录或注册关于 Samuel Asculai工作Enhance Skin Products学历Rutgers Grad School1973 毕业 · 新布朗斯维克所在地和家乡多伦多所在地多伦多家乡你关注的主页其他Philadelphia Magazine 、The Drafting Room - Exton, PA Beer Bar 、 I Used To Be Rich - I Used To Have Money、Contract Manufacturer of Skin Care - Phytogenx 、 Skin Care Hydration - Visible Youth - Best Moisturizers - Wrinkle Reducer、US Aging News &  Associations  - Samuel Asculai Editor in Chief 、 Dog Run Club、ynet 、 Visible Youth、CNNMoney 、 Air Canada、BookBub 、 LOLWOT、Forma Skincare 、 Shefi - Faran、 Petalwink: The Musical、Dana Milbank 、E.J. Dionne, Jr 、 Washington Post Opinions, Outlook, and PostEverything展开Philadelphia Magazine照片登录或创建帐户，即可查看 Samuel Asculai 的照片登录 Facebook新建 Facebook 帐户其他名字相似的用户Samuel J MaddenSamuel Camillo SilvaSamuel LeSamuel Mendaña GarcíaSamuel J ReillySamuel ChenSamuel BernierSamuel Wang联系方式无联系方式可显示中文(简体)English (US)日本語한국어Français (France)Bahasa IndonesiaPolskiEspañolPortuguês (Brasil)DeutschItalianoMessengerFacebook Lite用户地点游戏位置名人二手市场小组食谱彩色气球Instagram公司简介创建广告创建主页开发者招聘信息隐私权政策Cookie广告选项条款设置活动日志 Facebook © 2017




	
        Compensation Information for Samuel  Asculai , CSO of ENHANCE SKIN PRODUCTS INC | Salary.com
    


























Enterprise
Small Business
Personal




Contact Us
Log In


































Salaries
Jobs
Education
Advice
























 





Samuel  Asculai 
Executive Compensation
As CSO at ENHANCE SKIN PRODUCTS INC, Samuel  Asculai  made $63,000 in total compensation.  Of this total $0 was received as a salary, $0 was received as a bonus, $0 was received in stock options, $0 was awarded as stock and $63,000 came from other types of compensation. This information is according to proxy statements filed for the 2016 fiscal year. 


ENTER AN EXECUTIVE OR COMPANY NAME
New Search


Go



The chart on this page features a breakdown of the total annual pay for Samuel  Asculai ,  CSO at ENHANCE SKIN PRODUCTS INC as reported in their proxy statements. 
Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. ENHANCE SKIN PRODUCTS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. ENHANCE SKIN PRODUCTS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.
Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.
Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.



Other Executives at this Company


Drasko  Puseljic 
Donald  Nicholson 
Frode  Botnevik 







Samuel  Asculai 


Base Pay$0
Bonus + Incentive Comp$0
Total Cash Compensation$0


Stock Award Value$0
Option Award Value$0
Total Equity$0



Total Other$63,000



Total Compensation$63,000




Browse Executives by First Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z


Browse Companies by Company Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#



This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement. 
Use of Data / Disclaimer
The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.
What is a proxy statement?
A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.
The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.







    





 

 






     

privacy policy
terms of use
about us
contact us

©  Salary.com. All rights reserved.


US Salaries
Canadian Salaries
Purchase a Salary Report
Salaries by Category
Salaries by Income
Salaries by Industry
Popular Salaries
Negotiation Tips
Benefits Calculator
Search Job Openings
Job Openings by State
Job Openings by Category
Education by Career
Education by Level
Education by Major
Cost of Living Calculator
























 
 

Samuel Asculai's involvement in venture capital (via Enhance Skin Products Inc)































Want to see more?Want to find out who got funded, and who’s funding the next big thing? in real time? all across the world? tailored to your specific areas of focus?100+ deals per dayGet access to the most exhaustive worldwide funding watch on the web!Comprehensive funding informationKnow about who invested in a company, which sites covered the event, the funding history, etc.Exclusive insightsView original analytics such as most dynamic industries, most active investors, and more!Stay aware!Get emailed when deals critical to your business happen. Filter by region, industry and topics of interest.As seen onHave a login?Sign inRegister now!It's free!Use your social accountOr fill in the quick form:Register nowpromise we won't spamSign invia your social account:via your existing WGF account:Remember meRegister, it's freeForgot your password?SIGN INForgot your password?Enter your e-mail and we will send you your new password.reset passwordThe world's largest funding base/people/139400-samuel-asculaisection=people&subsection=detail&id=139400




			Search deals by company name, industry, location, investors...			
			




SEARCH


SamuelAsculaiGet alertedif Samuel Asculai gets funded!Samuel AsculaiEnhance Skin Products Inc - Executive Officer, DirectorDeals involving Samuel Asculai$16,000 raised with Enhance Skin Products Inc on May, 2013Please note that all data is automatically extracted and errors can occur.The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.Some of the profile information was collected using the Crunchbase API. For more details on the profile, please check Samuel Asculai on Crunchbase.Inaccurate Data? Help us improve WhoGotFunded: post a comment!

Samuel Asculai











































Home
Search
Sign-In/Up
Contracts
Dictionary
Clauses
Companies
People

About
FAQ
Blog








Follow Samuel Asculai contracts
Click to sign-up for email updates.

      Loading...
    





Home



Sample Contracts



By Executive


Samuel Asculai


Samuel Asculai

SEC Documents
Filings
Personal financials
Insider transactions
Previous Companies

Enhance Skin Products
(NASDAQ:EHSK)


Sample Contracts with Samuel Asculai



Enhance Skin Products –
Integumen Limited -And- INTEGUMEN INC. -And- ENHANCE SKIN PRODUCTS INC. -And-
DONALD NICHOLSON -And- DR SAMUEL S. ASCULAI ASSET PURCHASE AGREEMENT EVERSHEDS
One Earlsfort Centre Earlsfort Terrace Dublin 2
(October 5th, 2016)
1.     ENHANCE     SKIN PRODUCTS INC., a corporation incorporated in the State of Nevada, with Company Registration Number NV20061008677,     having its registered office at 50 West Liberty Street, Suite 880, Reno, NV 89501, United States of America (the "Seller");                        2.     INTEGUMEN     INC., a corporation incorporated in the State of Delaware, with Company Registration Number 6108396, having its registered     office at Corporation Trust Centre, 1209 Orange Street, Wilmington, New Castle County, Deleware 19801, United States of America     (the "Purchaser", which is a wholly owned subsidiary of Integumen);                   3.     INTEGUMEN     LIMITED a limited liability company incorporated in England and Wales, with Company Registration Number 10205396, having     its registered address Sand Hutton Applied Innovation Campus, Sand Hutton, York, North Yorkshire, YO41 1LZ, England (the "Integumen");                   4.     DONALD     NICHOLSON of 25 Weststand Ap



Enhance Skin Products –
AMENDMENT NO. 4 TO CONSULTING AGREEMENT B E T W E E N: SAMUEL ASCULAI of the
City of Toronto in the Province of Ontario (Hereinafter Referred to as the
"Principal") - And - BIOSTRATEGIES CONSULTING GROUP INC. A Corporation
Incorporated Pursuant to the Laws of the Province of Ontario (Hereinafter
Referred to as the "Consultant") - And - ENHANCE SKIN PRODUCTS INC. A
Corporation Incorporated Pursuant to the Laws of the State of Nevada
(Hereinafter Referred to as the "Corporation")
(October 5th, 2016)
WHEREAS the Corporation, Consultant and Principal are parties to a Consulting Agreement made effective March 5, 2013, Amendment No 1 to Consulting Agreement dated March 3, 2014, Amendment No 2 to Consulting Agreement effective August 1, 2015 and Amendment No 3 to Consulting Agreement effective March 21, 2016 (collectively the "Consulting Agreement");



Enhance Skin Products –
DATED July 7, 2016 ENHANCE SKIN PRODUCTS INC. -And- BIOSURFACE LIMITED OPTION
AGREEMENT Eversheds One Earlsfort Centre Earlsfort Terrace Dublin 2
(July 12th, 2016)
1.     ENHANCE     SKIN PRODUCTS INC., a corporation incorporated in the state of Nevada, with Company Registration Number NV20061008677,     having its registered address at 50 West Liberty Street, Suite 800, Reno, NV 89501, United States of America (the "Seller");     and                   2.     BIOSURFACE     LIMITED, a limited liability company incorporated in the United Kingdom, with Company Registration Number 10205396, having     its registered address Sand Hutton Applied Innovation Campus, Sand Hutton, York, North Yorkshire, YO41 1LZ, England (the "Purchaser").



Enhance Skin Products –
AMENDMENT NO. 3 TO CONSULTING AGREEMENT B E T W E E N: SAMUEL ASCULAI of the
City of Toronto in the Province of Ontario (Hereinafter Referred to as the
"Principal") - and - BIOSTRATEGIES CONSULTING GROUP INC. A Corporation
Incorporated Pursuant to the Laws of the Province of Ontario (Hereinafter
Referred to as the "Consultant") - and - ENHANCE SKIN PRODUCTS INC. A
Corporation Incorporated Pursuant to the Laws of the State of Nevada
(Hereinafter Referred to as the "Corporation")
(March 24th, 2016)
WHEREAS the Corporation, Consultant and Principal are parties to a Consulting Agreement made effective March 5, 2013, Amendment No 1 to Consulting Agreement dated March 3, 2014 and Amendment No 2 to Consulting Agreement effective August 1, 2015 (collectively the "Consulting Agreement");



Enhance Skin Products –
Contract
(March 24th, 2016)
LOAN AGREEMENT (Amendment 5) made effective March 21, 2016 (the "Effective Date") between Mercuriali Ltd., a limited company incorporated pursuant to the laws of England and Wales (hereinafter referred to as "Mercuriali") and Samuel Asculai of the City of Toronto (hereinafter "Asculai") and Enhance Skin Products Inc., a corporation incorporated pursuant to the laws of the State of Nevada (hereinafter referred to as "Enhance")



Enhance Skin Products –
Contract
(January 25th, 2016)
LOAN AGREEMENT (Amendment 4) made effective January 22, 2016 (the "Effective Date") between Mercuriali Ltd., a limited company incorporated pursuant to the laws of England and Wales (hereinafter referred to as "Mercuriali") and Samuel Asculai of the City of Toronto (hereinafter "Asculai") and Enhance Skin Products Inc., a corporation incorporated pursuant to the laws of the State of Nevada (hereinafter referred to as "Enhance")



Enhance Skin Products –
Contract
(October 5th, 2015)
LOAN AGREEMENT (Amendment 3) made effective September 29, 2015 (the "Effective Date") between Mercuriali Ltd., a limited company incorporated pursuant to the laws of England and Wales (hereinafter referred to as  "Mercuriali") and Samuel Asculai of the City of Toronto (hereinafter "Asculai") and Enhance Skin Products Inc., a corporation incorporated pursuant to the laws of the State of Nevada (hereinafter referred to as  "Enhance")



Enhance Skin Products –
As of July 31, 2013 ("Reporting Date"), Asculai Has Loaned Enhance $93,785
(Hereinafter the "Asculai Loan Amount"). The Asculai Loan Amount Will Be
Increased by Any Amount Loaned by Asculai to Enhance Since the Reporting Date
or During the Term of This Agreement.
(September 27th, 2013)




Enhance Skin Products –
Agreement and Plan of Merger by and Between Age Reversal, Inc., a Maryland
Corporation and Enhance Skin Products Inc., a Nevada Corporation
(September 6th, 2012)
THIS AMENDMENT TO AGREEMENT AND PLAN OF MERGER is made and entered into as of August 31, 2012, by and between Age Reversal, Inc., a Maryland corporation ("ARI"), and Enhance Skin Products Inc., a Nevada corporation ("ESP") ("Amendment").  Those capitalized terms used in this Amendment which are not defined in this Amendment shall have the definitions and meanings specified by the provisions of the Merger Agreement (defined hereinafter).



Enhance Skin Products –
Registration Rights Agreement
(August 6th, 2010)
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of July 29, 2010, by and between ENHANCE SKIN PRODUCTS INC., a Nevada corporation, (the "Company"), and CRISNIC FUND SA, a Costa Rican Investment corporation (together with it permitted assigns, the "Investor").  Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in Indirect Primary Offering Agreement by and between the parties hereto, dated as of the date hereof (as am ended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").



Enhance Skin Products –
Indirect Primary Offering Agreement
(August 6th, 2010)
THIS AGREEMENT dated as of the 29th day of July 2010 (the "Agreement") between Crisnic Fund, S.A., (the "Investor"), and Enhance Skin Products Inc., a corporation organized and existing under the laws of the State of Nevada (the "Company").



Enhance Skin Products –
Stock Purchase Agreement
(August 6th, 2010)
This Stock Purchase Agreement (the "Agreement") is dated as of this 29th  day of July, 2010 (the "Effective Date"), by and between Enhance Skin Products Inc., a Nevada corporation ("Seller"),  and Crisnic Fund SA ("Purchaser").



Enhance Skin Products –
Unaudited Pro Forma Consolidated Financial Statements
(November 10th, 2009)
The following pro forma balance sheet has been derived from the balance sheet of Zeezoo Software Corp, (" Zeezoo") at July 31, 2008 and adjusts such information to give effect to the acquisition of Enhance Skin Products, Inc., as if the acquisition had occurred at July 31, 2008. The pro forma balance sheet is presented for informational purposes only and does not purport to be indicative of the financial condition that would have resulted if the acquisition had been consummated at July 31, 2008. The pro forma balance sheet should be read in conjunction with the notes thereto and Enhance Skin Products Inc's financial statements and related notes thereto contained elsewhere in this filing.



Enhance Skin Products –
EMPLOYMENT AGREEMENT This Employment Agreement Made as of the 14th Day of
August , 2008.
(August 20th, 2008)
WHEREAS         the Corporation is desirous of engaging the Executive         in the         position of Chief Operating Officer and Vice President of Sales, of the         Corporation;



Enhance Skin Products –
Asset Purchase Agreement
(August 20th, 2008)
This       Asset Purchase Agreement is entered into as of August 14, 2008 (the "Agreement       Date") by and between Zeezoo Software Corp., a Nevada corporation (the "Purchaser") and Enhance Skin Products Inc., a Province of Ontario, Canada       corporation (the "Seller).



Enhance Skin Products –
Employment Agreement
(August 20th, 2008)
WHEREAS       the Corporation is desirous of employing the Executive       in the       position of President and Chief Executive Officer of the       Corporation;



Enhance Skin Products –
Contract
(July 29th, 2008)
Exhibit 10.1                                ZEEZOO SOFTWARE CORP.                           2033 GATEWAY PLACE, 6TH FLOOR                                 SAN JOSE CA 95110  June 17, 2008   NON-BINDING OFFER TO FINANCE ENHANCE SKIN PRODUCTS, INC.  This  Offer to  Finance  is  non-binding  on  either  party and is  intended  to establish a basis for future discussions and a definitive  investment  agreement between  Zeezoo  Software  Corp.  ("Zeezoo")  and Enhance  Skin  Products,  Inc. ("Enhance").  This Offer to Finance is subject to the  parties  entering  into a binding definitive investment agreement. Subject to the foregoing, Zeezoo offers to finance  Enhance on the following  terms that are to be more fully set out in the definitive investment agreement:  1.   Zeezoo's  present  management  will transfer  27,500,000 of their shares to      Enhance to acquire all the assets of Enhance,  including but not limited to      Patents, Trademarks, and intellectual property.  2.   Concurre





Follow Samuel Asculai contracts
Click to sign-up for email updates.

      Loading...
    












×









      Have an account? Sign in here.

Law Insider
Recover your password







No account? Register Now!


No account? Register Now!
Sign in
by using one of this services











or







Forgot your password?


Have an account? Sign in here.
Join Law Insider
for Free
by using one of this services











or







By registering you agree to our
      terms of service.










Contract and Agreement Category List











































Home
Search
Sign-In/Up
Contracts
Dictionary
Clauses
Companies
People

About
FAQ
Blog







Sample Contract Categories 

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o

p

q

r

s

t

u

v

w

x

y

z


abcdefghijklmnopqrstuvwxyz


337k
		Delaware
	

277k
		New York
	

113k
		California
	

70k
		Texas
	

68k
		Agreement
	

62k
		Nevada
	

46k
		Florida
	

44k
		Maryland
	

40k
		Illinois
	

38k
		Employment Agreement
	

38k
		Washington
	

37k
		Amended And Restated
	

36k
		Massachusetts
	

34k
		New Jersey
	

33k
		Pennsylvania
	

28k
		Georgia
	

28k
		Colorado
	

26k
		Ohio
	

25k
		Minnesota
	

25k
		Virginia
	

21k
		North Carolina
	

20k
		Incentive Plan
	

19k
		Credit Agreement
	

19k
		Amendment
	

16k
		Connecticut
	

16k
		Michigan
	

15k
		Indiana
	

14k
		Registration Rights Agreement
	

14k
		Recitals
	

13k
		Tennessee
	

13k
		Arizona
	

13k
		Missouri
	

12k
		Purchase Agreement
	

12k
		Promissory Note
	

12k
		Indenture
	

11k
		Warrant
	

11k
		Louisiana
	

11k
		Kansas
	

11k
		Utah
	

11k
		Wisconsin
	

10k
		Oklahoma
	

9k
		Securities Purchase Agreement
	

9k
		Agreement And Plan Of Merger
	

8k
		Iowa
	

8k
		Supplemental Indenture
	

8k
		Note
	

8k
		Equity Incentive Plan
	

7k
		Kentucky
	

7k
		Stock Purchase Agreement
	

7k
		Alabama
	














×









      Have an account? Sign in here.

Law Insider
Recover your password







No account? Register Now!


No account? Register Now!
Sign in
by using one of this services











or







Forgot your password?


Have an account? Sign in here.
Join Law Insider
for Free
by using one of this services











or







By registering you agree to our
      terms of service.









Samuel Asculai 的个人主页 | Facebook


Facebook邮箱或手机号密码忘记帐户？中文(简体)English (US)日本語한국어Français (France)Bahasa IndonesiaPolskiEspañolPortuguês (Brasil)DeutschItalianoMessengerFacebook Lite用户地点游戏位置名人二手市场小组食谱彩色气球Instagram公司简介创建广告创建主页开发者招聘信息隐私权政策Cookie广告选项条款设置活动日志 Facebook © 2017
















 


Presenting pure hydration for the skin | Visible Youth













Contact Us
Filings
Stock Quotes
News
About Us
Home


 




Company Overview
Meet the Team
             

What is Hyaluronic Acid?
Scientific Studies
Products
Legal Notices




MANAGEMENT
    				Donald Nicholson 
Samuel Asculai
Drasko Puseljic 
		                                       
BOARD OF DIRECTORS				
					Frode Botnevik 




Donald Nicholson
President & Chief Executive Officer and Director
Mr. Nicholson holds a BCom Law degree (with Honors) in Business and Law from the University of Edinburgh.  Mr. Nicholson is a member of the Institute of Chartered Accountants of Scotland has more than 27 years of experience in the healthcare industry. Mr. Nicholson is, currently, the founding shareholder, and Chief Executive Officer of Mercuriali Ltd., a development stage United Kingdom private healthcare company. Prior to that, Mr. Nicholson was the founding shareholder and Chief Financial Officer of Stravencon Ltd., a European developer and marketer of generic pharmaceutical products manufactured in China. Prior to that he was Chief Financial Officer of SkyePharma Plc a UK specialty pharmaceutical company listed on the London market and on the US Nasdaq market. He was also a Director of SkyePharma Plc. Mr. Nicholson held a number of positions with Wellcome plc and Corange Ltd, the holding company of Boehringer Mannheim and DePuy, where he was corporate strategy and finance director. Mr. Nicholson has extensive experience in product and company acquisitions and disposals, in and out-licensing arrangements, sale/royalty agreements and financial strategy and funding structures. His industry experience includes Pharmaceuticals, Biochemicals, Orthopaedics, Diagnostics and Drug Delivery including Dermatology. 



Sam Asculai
Chairman of Board and Chief Scientific Officer

Dr. Asculai, the holder of a Masters degree and a Ph.D. in Microbiology from Rutgers University, has more than 40 years of experience in the life science industry.  Dr. Asculai is the inventor on over 50 U.S. patents, including over 30 patents related to hyaluronic acid, the cornerstone of Enhance Skin Products Inc.’s product line.  Over the course of his career, Dr. Asculai has contributed to the development of products that have achieved cumulative sales of close to two billion dollars including, Monistat, Delfen Cream for herpes virus infectons, Ganciclovir, Solaraze, and MACI. 

Immediately prior to his current role, Dr. Asculai was the sole owner of a private company whose assets form the basis for Enhance Skin Products Inc.’s operations. For ten years, Dr. Asculai served as Chief Executive Officer of Hyal Pharmaceutical Corporation where he developed the technology underpinning the Visible Youth™ brand. There he also invented and developed Solaraze a topical treatment for actinic keratosis, a precancerous skin condition that is commonly referred to as sunspots.  

Dr. Asculai also held senior positions with Verigen AG, a tissue engineering company; ens Bio-Logicals ; Monsanto Corporation, a multinational agricultural biotechnology company; and the Ortho Pharmaceutical Corporation division of Johnson & Johnson, a multinational pharmaceutical company.


Drasko Puseljic 
General Counsel
Mr. Puseljic is the holder of a B.Sc., Honours in Biology from McMaster University, an LL.B. from Osgoode Hall Law School and an M.B.A from the University of Toronto. He has held legal and/or business development roles at Hyal Pharmaceutical Corporation, Visible Genetics Inc., Verigen AG and Enhance Skin Products Inc., a private company whose assets are the basis for the Company’s operations. He also has investment banking experience with Eureka Capital Markets, a boutique investment bank. Currently, in addition to his role with Enhance Skin Products, Mr. Puseljic is a senior consultant with Kidd Consultants LLC, a firm providing financial and strategic consulting services internationally to life sciences companies.


BOARD OF DIRECTORS
Frode Botnevik 
Director
Mr. Botnevik is a partner of Management & Finance AS, a Norwegian financial consulting firm that provides services in the areas of project and export financing, structured finance, risk management, financial restructuring, strategic partners and mergers and acquisitions. Mr. Botnevik has over 30 years of experience of industrial and financial experience and has been involved in the process of listing companies on the Oslo and Singapore stock exchanges and on Nasdaq. Mr. Botnevik has served on the boards of directors of companies in more than twelve countries.


Monistat, Delfen, Solaraze and MACI are trademarks of their respective owners  







Samuel S. Asculai, PhD - Biography

















































































Log in






E-mail



Password







Remember




Forgot password ?









Become a member for free
Sign up





Sign up




New memberSign up for FREE


New customerDiscover our portfolios












 United States
 United Kingdom
 France
 Deutschland
 Schweiz (DE)
 Suisse (FR)










Settings

            Dynamic quotes 


OFFON

















Markets
Equities
North AmericaEuropeAsiaOceaniaMiddle East� More Equities

Indexes
DOW JONESS&P 500NASDAQ 100TSX COMPFTSE 100� More Indexes

Currency / Forex
EUR / USDGBP / USDUSD / JPYUSD / CADAUD / USD� More Currencies

Commodities
GOLDCrude Oil (WTI)Crude Oil (BRENT)SILVERPLATINUM� More Commodities


 News
Latest News
CompaniesMarketsEconomyCurrency / ForexCommoditiesInterest RatesBusiness LeadersFinancial calendarEconomic calendar

Listed company
Analyst reco.RumorsIPOsCapital Markets TransactionsNew ContractsProfits warningsAppointmentsPress ReleasesEventsCorporate actions

Sector News
EnergyBasic MaterialsIndustrialsConsumer CyclicalConsumer Non-CyclicalFinancialsHealthcareTechnologyTelecommunications ServicesUtilities


 Analysis
All AnalysisCommentariesIndex AnalysisStock Trading StrategiesCommodity AnalysisForex Analysis

 Stock Picks
All stock picks

 Portfolios
My Portfolio
Virtual portfolios
4-Traders Portfolios
European PortfolioUSA PortfolioAsian Portfolio


 Screeners
Market Screener HomeFundamental Analyse
Top Investor RatingTop Trading RatingTop ConsensusGrowth stocksYield stocksLow valuations

Technical Analysis
Oversold stocksOverbought stocksClose to resistancesClose to supportsAccumulation phaseMost volatile stocks


 Watchlists
My Watchlists
Watchlists
Top Lists
Yield stocksGrowth stocksUndervalued Stocks


 Top / Flop
Top News
Most Read NewsHot News

Top Fundamentals
Top CapitalizationTop YieldTop PERTop ConsensusTop Fundamentals

Top Technicals
Top RSIUnusual volumesTop GapsTop STIM

Top Movers
Top USATop CanadaTop U.K.Top GermanyTop EuropeTop Asia


 Tools
Market ScreenerDynamic chartFinancial calendarEconomic calendarSector researchCurrency converter

 Our Services
Premium AccessDiscover our Services

 



















 






4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography


Business Leaders




Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors HomeAll newsMost read newsBusiness Leaders Biography


 
















Samuel S. Asculai, PhD

Age : 73Public asset : 105,956 USDLinked companies :  Enhance Skin Products Inc 





Summary 



Dr. Samuel S. Asculai is Chairman & Chief Scientific Officer at Enhance Skin Products, Inc.He  is on the Board of Directors at Verigen, Inc. Dr. Asculai was previously employed as Chief Executive Officer by Verigen AG, Chief Executive Officer by Hyal Pharmaceutical Corp., Vice President-Operations by ENS Biologicals, Inc., and Manager-Research & Development by Monsanto Co. /Old/. He received his undergraduate degree from Pace University, a graduate degree from Rutgers University (New Jersey) and a doctorate degree from Rutgers University (New Jersey).



Current positions of Samuel S. Asculai, PhD 









 NameTitle
Since
 Enhance Skin Products Inc(Personal Products)
Chairman & Chief Scientific Officer
2008Verigen, Inc.
President, Chief Executive Officer & Director
-



Holdings of Samuel S. Asculai, PhD 










 NameEquities%Valuation

Enhance Skin Products Inc.52,978,04415.7%105,956 USD



Samuel S. Asculai, PhD: Personal Network 







 NameLinked companies

Frode Botnevik Verigen, Inc.Enhance Skin Products Inc 

Donald Nicholson Enhance Skin Products Inc 

Drasko Puseljic Enhance Skin Products Inc 

Keith Thomson Verigen, Inc. 




Most Read News 




07/19 JAMIE DIMON : JPMorgan's Jamie Dimon lashes out against Washington politics



07/19 DAVID HENRY : JPMorgan posts higher profit; shares dip on net interest income view



07/19DJJAMES MURDOCH : Top Energy News of the Day



07/19 RUPERT MURDOCH : Murdochs warn UK a delay to Sky-Fox deal could hit inward investment



07/19 PHILIP GREEN : Philip Green poaches Burberry man to be TopShop CEO



07/20 THOMAS WILSON : Most Japanese companies look to raise retirement age - Reuters poll



07/20 RUPERT MURDOCH : Murdoch made to wait few more weeks for Britain's Fox-Sky decision



07/21DJMUKESH AMBANI : Reliance's Ambani Launches Low-Cost Mobile Phone for India



07/21DJINDRA NOOYI : PepsiCo 'Stretches' Managers At Top -- WSJ



07/20DJSOREN SCHRODER : Top Stories of the Day



More news

 


            © 2017 People and Ownership :    









Advertisement








Samuel S. Asculai, PhD : Connections 



 Enhance Skin Products Inc









Frode BotnevikDonald NicholsonDrasko Puseljic




 Ultra Electronics Holdings plc









Keith Thomson




Vision RT Ltd.
                                            








Keith Thomson





Verigen, Inc.
                                            








Frode Botnevik





Management & Finance AS
                                            








Frode Botnevik





The Institute of Chartered Accountants of Scotland
                                            








Donald Nicholson





Mercuriali Ltd.
                                            








Donald Nicholson





Phynova Group Ltd.
                                            








Keith Thomson





Visible Youth Ltd.
                                            








Donald Nicholson





 







Popular Business Leaders 


 

Bernard Arnault
Mary Barra
Lloyd Blankfein
Michael Bloomberg
Yannick Bollor�
Warren Buffett
Jean-paul Clozel
Gary Cohn
Marc De Lacharri�re
Jamie Dimon
Ralph Dommermuth
Sebastian Ebel
John Edwards
David Einhorn
Jeff Fettig
Mark Fields
Carlos Ghosn
Terry Gou
David Henry
Carl Icahn
Michel Landel
Robin Li
Daniel Loeb
Maurice L�vy
Jack Ma
Marissa Mayer
Lakshmi Mittal
Rupert Murdoch
Elon Musk
Peter Nicholas
John Paulson
Nelson Peltz
Georges Plassat
Hasso Plattner
Thomas Rabe
Giuseppe Recchi
Wolfgang Reitzle
Wilbur Ross
Charles Schwab
Igor Sechin
Pascal Soriot
George Soros
Rupert Stadler
Bernard Tapie
Patrick Thomas
John Williamson
Thomas Wilson
Dieter Zetsche
Mark Zuckerberg



A-Z Business Leaders




 



























4-traders.com :MarketsNewsAnalysisStock PicksPortfoliosScreenersWatchlistsTop / FlopToolsOur ServicesAbout :Surperformance SASContact usAdvertiseLegal informationsAbout usStay Connected :FacebookTwitterPartners :B�rse: Aktien, Kurse und NachrichtenBest tweets 




   Copyright � 2017 Surperformance. All rights reserved.  












 




















Slave





